Status:
UNKNOWN
Cerebral Bleeding in COVID-19 ARDS Patients on Veno-venous ECMO
Lead Sponsor:
University of Zurich
Collaborating Sponsors:
Hannover Medical School
University Hospital, Bonn
Conditions:
Acute Respiratory Distress Syndrome
Extracorporeal Membrane Oxygenation Complication
Eligibility:
All Genders
18+ years
Brief Summary
Critically ill patients with severe acute respiratory distress syndrome (ARDS) sometimes require treatment with veno-venous extracorporeal membrane oxygenation (ECMO) to support gas exchange. To preve...
Detailed Description
The primary aim of the project is to retrospectively analyze the incidence of bleeding complications (especially cerebral bleedings) in critically ill COVID-19 patients with ARDS requiring ECMO suppor...
Eligibility Criteria
Inclusion
- Critically ill patients with ARDS requiring ECMO support from all three study sites
- age \> 18 years
Exclusion
- \- Presence of an objective, declared denial to participate
Key Trial Info
Start Date :
April 30 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2021
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT04853953
Start Date
April 30 2021
End Date
December 1 2021
Last Update
April 22 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.